clinical trial · NCT04366726
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
Radius Health, Inc.·phase1·completed·n = 22
Postmenopausal Osteoporosisabaloparatide-sMTS
brief summary
This was an open-label, single-center study to evaluate the usability of abaloparatide-sMTS by participants with low BMD.
started
Apr 9, 2019
primary completion
May 14, 2019
completion
May 14, 2019
last updated
Nov 22, 2023
detailed description
This study aimed to evaluate the ability of participants to self-administer 300 μg abaloparatide-sMTS over a period of 29 days based on PK and PD markers.
official title
A Prospective, Single Arm Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Usability of Abaloparatide-sMTS in Postmenopausal Women With Low Bone Mineral Density
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol